v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Cash flows from operating activities:    
Net income $ 64,256,000 $ 47,185,000
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 19,578,000 19,012,000
Stock-based compensation expense 10,783,000 8,728,000
Deferred income taxes 9,676,000 7,934,000
Provision for doubtful accounts 5,110,000 5,965,000
Impairment of right-of-use assets 0 1,629,000
Impairment of fixed assets 0 123,000
Gain on marketable securities (14,185,000) (12,796,000)
Gain on cash surrender value of life insurance policies (2,246,000) (1,966,000)
Change in other assets and liabilities:    
Deferred compensation 22,938,000 27,453,000
Receivables due from clients (37,115,000) (28,697,000)
Income taxes and other receivables (9,003,000) (164,000)
Prepaid expenses and other assets (7,023,000) (8,039,000)
Unearned compensation (16,386,000) (21,713,000)
Income taxes payable (964,000) 3,478,000
Accounts payable and accrued liabilities (272,117,000) (321,491,000)
Other (487,000) (1,128,000)
Net cash used in operating activities (227,185,000) (274,487,000)
Cash flows from investing activities:    
Purchase of property and equipment (10,497,000) (15,659,000)
Purchase of marketable securities (11,181,000) 0
Proceeds from sales/maturities of marketable securities 8,351,000 18,008,000
Proceeds from life insurance policies 93,000 9,332,000
Premium on company-owned life insurance policies (13,502,000) (238,000)
Net cash (used in) provided by investing activities (26,736,000) 11,443,000
Cash flows from financing activities:    
Dividends paid to stockholders (19,800,000) (9,627,000)
Repurchases of common stock (23,488,000) (5,138,000)
Payments of tax withholdings on restricted stock (16,625,000) (10,175,000)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 4,248,000 4,696,000
Principal payments on finance leases (412,000) (382,000)
Net cash used in financing activities (56,077,000) (20,626,000)
Effect of exchange rate changes on cash and cash equivalents 2,369,000 1,855,000
Net decrease in cash and cash equivalents (307,629,000) (281,815,000)
Cash and cash equivalents at beginning of period 941,005,000 844,024,000
Cash and cash equivalents at end of the period $ 633,376,000 $ 562,209,000

Source